For Immediate Release
Media Contact: Bob Cooper
Date: July 20, 2004
Idahoans to Receive More Than $162,000 for BuSpar Claims
(Boise) - Attorney General Lawrence Wasden announced that more than $162,000 in settlement checks were mailed to 276 Idahoans on July 19, 2004. Those Idahoans will receive a letter of explanation with their checks in the next few days.
Idahoans who submitted claims for purchases of the anti-anxiety drug BuSpar will receive the refunds. Individuals and organizations that purchased BuSpar between January 1, 1998 and January 31, 2003 and filed valid claims during the court-established claims period ending December 5, 2003, will receive a refund. The amount of the refund is determined by the amount of BuSpar purchased. The average refund is $588.
The restitution payments are a result of an antitrust suit that was settled on March 7, 2003 against Bristol-Myers Squibb Co., Watson Pharma, Inc. and Danbury Pharmacal, Inc.
Idaho and 34 other states, the District of Columbia and Puerto Rico, had alleged that Bristol and the other defendants acted in violation of state and federal antitrust laws to prevent generic BuSpar from coming to the marketplace.
BuSpar is a prescription drug, which is used for treating patients suffering from general anxiety disorder.
The State of Idaho will also receive $175,000 based upon Medicaid and state agency purchases of BuSpar.
- End -